1.
R P, Bashir S. CRITICAL REVIEW OF PHARMACOGENOMICS IN ANTIPARKINSONIAN DRUG THERAPY: IMPACT ON CLINICAL MANAGEMENT OF PARKINSON’S DISEASE. Asian J Pharm Clin Res [Internet]. 2016 Nov. 1 [cited 2024 Oct. 5];9(6):24-7. Available from: https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/13350